Morgan Stanley’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Sell |
474,702
-45,237
| -9% | -$1.96M | ﹤0.01% | 2769 |
|
|
2025
Q1 | $19.4M | Buy |
519,939
+310,405
| +148% | +$11.6M | ﹤0.01% | 2723 |
|
|
2024
Q4 | $9.49M | Sell |
209,534
-28,736
| -12% | -$1.3M | ﹤0.01% | 3456 |
|
|
2024
Q3 | $14M | Buy |
238,270
+3,490
| +1% | +$205K | ﹤0.01% | 3148 |
|
|
2024
Q2 | $9.24M | Buy |
234,780
+98,642
| +72% | +$3.88M | ﹤0.01% | 3385 |
|
|
2024
Q1 | $9.05M | Buy |
136,138
+740
| +0.5% | +$49.2K | ﹤0.01% | 3428 |
|
|
2023
Q4 | $3.78M | Buy |
135,398
+103,916
| +330% | +$2.9M | ﹤0.01% | 4540 |
|
|
2023
Q3 | $671K | Buy |
+31,482
| New | +$671K | ﹤0.01% | 5015 |
|